You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 11, November 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Scapuloperoneal Syndromes

Absence of Linkage to the 4q35 FSHD Locus

Rabi Tawil, MD; Gary J. Myers, MD; Barbara Weiffenbach, PhD; Robert C. Griggs, MD

Arch Neurol. 1995;52(11):1069-1072.


Abstract

Objective
To investigate whether two forms of the scapuloperoneal syndrome result from genetic defects allelic to facioscapulohumeral dystrophy (FSHD).

Design
Two kindreds with scapuloperoneal syndromes underwent clinical, histologic, and electrophysiologic evaluation followed by genetic evaluation with probes closely linked to FSHD.

Results
Although the proband in each kindred had facial, scapular stabilizer, and humeral weakness, raising the possibility of FSHD, evaluation of multiple other affected family members showed patterns of involvement that were clinically distinct from typical FSHD. In addition, DNA studies showed no linkage to the 4q35 FSHD locus in either kindred.

Conclusion
We conclude that these two forms of the scapuloperoneal syndrome are genetically distinct from FSHD.



Author Affiliations

From the Departments of Neurology (Drs Tawil, Myers, and Griggs) and Pediatrics (Dr Myers), School of Medicine and Dentistry, University of Rochester (NY); the Collaborative Research Division, Genome Therapeutic Corp, Waltham, Mass (Dr Weiffenbach); and the Wayne C. Gorell, Jr, Molecular Biology Laboratory, Rochester (Drs Tawil, Myers, and Griggs).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy
Felice et al.
Neurology 2000;54:1927-1931.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.